Skip to content
Screener

Alkermes ALKS Total Current Assets

Total Current Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$28.58B-14.0%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$4.58B+11.0%
AbbVie logo
AbbVieABBV
$33.53B+21.2%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$611.21M+23.6%
Indivior Pharmaceuticals, Inc. logo
Indivior Pharmaceuticals, Inc.INDV
$667M-24.5%
LBR
LB Pharmaceuticals IncLBRX
$389.07M

Other financials

Income statement

See full
Revenue$496.0M+27.0%
Gross profit$397.9M+16.6%
Operating income$18.4M-80.3%
Net income$501.0K-99.4%
EPS (diluted)$0.00-100%

Balance sheet

See full
Cash & equivalents$511.5M-1.9%
Total debt$1.6B+2,064%
Total equity$1.8B+11.3%
Total assets$4.4B+95.0%

Cash flow

See full
Operating cash flow-$165.7M-268%
CapEx$8.1M-37.4%
Free cash flow-$169.8M-291%

Valuation

See full
Market cap$8.32B+89.9%
Enterprise value$9.38B+139%
P/E125.9×+113×
P/S+2.1×

Profitability

See full
Gross margin84.6%-0.6pp
Operating margin7%-17.8pp
Net margin4%-19.2pp
FCF margin14.2%-17.6pp

Returns & leverage

See full
Return on equity3.9%-20.1pp
Debt / equity0.9×+0.8×
Current ratio2.3×-0.9×

Where this comes from

Reported directly by Alkermes in its filing.

Tagged under the XBRL concept us-gaap:AssetsCurrent.

The source filing: Alkermes’s 10-Q, filed July 28, 2026.

Filed
Jul 28, 2026, 9:22 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-319022
Line itemJune 30, 2026December 31, 2025
Receivables, net456,477334,025
Inventory298,957196,625
Prepaid expenses and other current assets110,89579,090
Total current assets1,522,9061,929,161
PROPERTY, PLANT AND EQUIPMENT, NET218,284221,722
INVESTMENTS—LONG-TERM35,054145
RIGHT-OF-USE ASSETS76,11177,209
INTANGIBLE ASSETS, NET1,761,456815

Item 1. Condensed Consolidated Financial Statements:

FAQ

What is Alkermes's total current assets?
Alkermes (ALKS) reported total current assets of $1.52B in Q2 2026.
How has Alkermes's total current assets changed year-over-year?
Alkermes's total current assets decreased by 6.9% year-over-year, from $1.64B to $1.52B.
What is the long-term trend for Alkermes's total current assets?
Over 5 years (2020 to 2025), Alkermes's total current assets has grown at a 11.7% compound annual growth rate (CAGR), from $1.11B to $1.93B.
What does total current assets mean?
The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.

Ask your AI about Alkermes's total current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude